Skip to main content
Journal cover image

A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS

Publication ,  Conference
Desjardins, A; Vredenburgh, JJ; Gururangan, S; Peters, KB; Friedman, AH; Friedman, H; Reardon, DA
Published in: NEURO-ONCOLOGY
2009

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

2009

Volume

11

Issue

5

Start / End Page

633 / 633

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Vredenburgh, J. J., Gururangan, S., Peters, K. B., Friedman, A. H., Friedman, H., & Reardon, D. A. (2009). A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS. In NEURO-ONCOLOGY (Vol. 11, pp. 633–633).
Desjardins, Annick, James J. Vredenburgh, Sridharan Gururangan, Katherine B. Peters, Allan H. Friedman, Henry Friedman, and David A. Reardon. “A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS.” In NEURO-ONCOLOGY, 11:633–633, 2009.
Desjardins A, Vredenburgh JJ, Gururangan S, Peters KB, Friedman AH, Friedman H, et al. A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS. In: NEURO-ONCOLOGY. 2009. p. 633–633.
Desjardins, Annick, et al. “A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS.” NEURO-ONCOLOGY, vol. 11, no. 5, 2009, pp. 633–633.
Desjardins A, Vredenburgh JJ, Gururangan S, Peters KB, Friedman AH, Friedman H, Reardon DA. A PHASE II STUDY OF BEVACIZUMAB PLUS ETOPOSIDE AMONG RECURRENT MALIGNANT GLIOMA PATIENTS. NEURO-ONCOLOGY. 2009. p. 633–633.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

2009

Volume

11

Issue

5

Start / End Page

633 / 633

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences